SHARE

A2 Milk raises full-year sales outlook as NZ$2bn target nears

The infant-formula and fresh-milk producer saw H1 FY2026 revenue up 18.8% to NZ$993.5m, led by US and China/Asia growth. EBITDA climbed 18.4% to NZ$155m, with infant formula and milk driving stronger-than-expected performance.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.